Genes & DiseasesPub Date : 2025-01-12DOI: 10.1016/j.gendis.2025.101531
Jin Wang , Kexin Shen , Hongxia Lou , Lina Zhou , Yunfei An , Xiaodong Zhao , Yuan Ding
{"title":"Clinical relevance of loss-of-function mutations of NEMO/IKBKG","authors":"Jin Wang , Kexin Shen , Hongxia Lou , Lina Zhou , Yunfei An , Xiaodong Zhao , Yuan Ding","doi":"10.1016/j.gendis.2025.101531","DOIUrl":"10.1016/j.gendis.2025.101531","url":null,"abstract":"<div><div>Dysfunctional inhibitor of nuclear factor-κB (NF-κB) kinase regulatory subunit gamma (<em>IKBKG</em>) is known to trigger incontinentia pigmenti (IP), anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID), immunodeficiency (ID), and <em>IKBKG</em> deleted exon 5 autoinflammatory syndrome (NDAS). The correlation between genotype and phenotype remains elusive because of the considerable variability in <em>IKBKG</em> genes. This study aimed to systematically describe <em>IKBKG</em> gene mutations and clinical characteristics. Cases with <em>IKBKG</em> mutations and thorough clinical features were gathered using PubMed, Web of Science, EMBASE, Scopus, and Cochrane databases, with a publication deadline of February 12, 2023. The Newcastle-Ottawa scale and its modified version were used to assess the quality of each study. Gene mutations and clinical manifestation data were analyzed and reviewed. 144 publications with 564 patients were included in the analysis. IP, EDA-ID, ID, and NDAS accounted for 78.0%, 15.8%, 5.0%, and 1.2% of <em>IKBKG</em> mutations, respectively. Skin abnormalities (89.5%), dental abnormalities (68.5%), infection (100%), and non-infectious inflammation (100%) were the most common manifestations of IP, EDA-ID, ID, and NDAS, respectively. Mutations related to EDA-ID and ID are concentrated in the zinc finger region and characterized by the most severe clinical symptoms. E390RfsX5 can cause IP, EDA-ID, and ID. c.1182_1183delTT and H413R caused the most clinical manifestations. <em>Mycobacterium</em> (22.7%) and <em>Streptococcus</em> (17.5%) were the most common pathogens. Almost all cases of hyper-IgM occurred in patients with EDA-ID. Different structural domains correspond to symptoms with varying degrees of severity. Certain mutations may correspond to unique manifestations, providing insight into disease progression.</div></div>","PeriodicalId":12689,"journal":{"name":"Genes & Diseases","volume":"12 5","pages":"Article 101531"},"PeriodicalIF":6.9,"publicationDate":"2025-01-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144331140","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Genes & DiseasesPub Date : 2025-01-10DOI: 10.1016/j.gendis.2025.101528
Meng Ao , Shunxiang Zhang , Yun Ouyang , Shucong Li , Heqian Ma , Meizhen Guo , Xuelin Dai , Qianhui Xia , Xiaoying Zhang
{"title":"A novel mutation in the KLHL17 gene is associated with neurodevelopmental disorders","authors":"Meng Ao , Shunxiang Zhang , Yun Ouyang , Shucong Li , Heqian Ma , Meizhen Guo , Xuelin Dai , Qianhui Xia , Xiaoying Zhang","doi":"10.1016/j.gendis.2025.101528","DOIUrl":"10.1016/j.gendis.2025.101528","url":null,"abstract":"","PeriodicalId":12689,"journal":{"name":"Genes & Diseases","volume":"12 5","pages":"Article 101528"},"PeriodicalIF":6.9,"publicationDate":"2025-01-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144185659","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Genes & DiseasesPub Date : 2025-01-10DOI: 10.1016/j.gendis.2025.101524
Huamin Yin , Lian Duan , Zhendong Wang , Li Liu , Jingling Shen
{"title":"Fibroblast growth factor 8: Multifaceted role in development and developmental disorder","authors":"Huamin Yin , Lian Duan , Zhendong Wang , Li Liu , Jingling Shen","doi":"10.1016/j.gendis.2025.101524","DOIUrl":"10.1016/j.gendis.2025.101524","url":null,"abstract":"<div><div>Fibroblast growth factor 8 (FGF8), a secreted signaling molecule, involves in regulating cell survival, proliferation, migration, and differentiation. It exhibits a highly dynamic gene expression pattern throughout embryonic development, participates in craniofacial structures, limbs, internal organs, brain development, and is crucial during organogenesis. The dysregulation of precise localization and dosage of FGF8 at distinct embryonic stages can lead to developmental multiorgan abnormalities. This comprehensive review explores the <em>FGF8</em> expression in humans and mice, summarizes the involvement of FGF8 in various tissues including craniofacial, limbs, cardiovascular and urogenital system, nephrogenesis, lung, and brain development as well as developmental abnormalities resulting from the aberrant regulations of FGF8 such as skeletal abnormalities, ciliopathies, and holoprosencephaly.</div></div>","PeriodicalId":12689,"journal":{"name":"Genes & Diseases","volume":"12 5","pages":"Article 101524"},"PeriodicalIF":6.9,"publicationDate":"2025-01-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144261498","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Genes & DiseasesPub Date : 2025-01-08DOI: 10.1016/j.gendis.2025.101525
Hui-Qi Qu , Joseph T. Glessner , Charlly Kao , Hakon Hakonarson
{"title":"Data-informed insights into sex differences in peripheral blood mononuclear cells from single-cell transcriptomics","authors":"Hui-Qi Qu , Joseph T. Glessner , Charlly Kao , Hakon Hakonarson","doi":"10.1016/j.gendis.2025.101525","DOIUrl":"10.1016/j.gendis.2025.101525","url":null,"abstract":"","PeriodicalId":12689,"journal":{"name":"Genes & Diseases","volume":"12 5","pages":"Article 101525"},"PeriodicalIF":6.9,"publicationDate":"2025-01-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144185658","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Genes & DiseasesPub Date : 2025-01-08DOI: 10.1016/j.gendis.2025.101521
Xiujuan Wu , Xuanni Tan , Yangqiu Bao , Wenting Yan, Yi Zhang
{"title":"Landscape of metabolic alterations and treatment strategies in breast cancer","authors":"Xiujuan Wu , Xuanni Tan , Yangqiu Bao , Wenting Yan, Yi Zhang","doi":"10.1016/j.gendis.2025.101521","DOIUrl":"10.1016/j.gendis.2025.101521","url":null,"abstract":"<div><div>Breast cancer, the most prevalent cancer in women, poses a significant threat to their health. One of the prominent characteristics of malignant transformation in breast cancer cells is metabolic reprogramming, which encompasses glucose, lipid, and amino acid metabolism. Notably, breast cancer cells exhibit augmented energy metabolism and heightened glycolysis. In addition, there is an escalated demand for glutamine, which is met through intrinsic synthesis, uptake from extracellular sources via membrane transport proteins, or up-regulation of key metabolic enzymes in the glutamine metabolism pathway. Lipids not only serve as an energy source for tumor cells but also function as signaling molecules for intercellular communication. Extensive research in recent years has focused on unraveling the intricate mechanisms underlying metabolic reprogramming. Consequently, genes implicated in these processes have emerged as clinical therapeutic targets for cancer treatment. This review provides a comprehensive summary of the common metabolic alterations observed in cancer cells, discusses the factors and regulatory mechanisms influencing these changes, and explores potential therapeutic targets and strategies within the realm of cancer metabolism.</div></div>","PeriodicalId":12689,"journal":{"name":"Genes & Diseases","volume":"12 5","pages":"Article 101521"},"PeriodicalIF":6.9,"publicationDate":"2025-01-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144222127","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}